CenterBook Partners’s Roivant Sciences ROIV Stock Holding History

CenterBook Partners’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88M	Sell	53,116 -83,722	-61%	-$2.47M	0.09%	243
2026 Q1	$3.79M	Sell	136,838 -474,995	-78%	-$12.2M	0.2%	129
2025 Q4	$13.3M	Buy	611,833 +364,390	+147%	+$7.19M	0.65%	28
2025 Q3	$3.74M	Buy	247,443 +147,453	+147%	+$1.83M	0.19%	152
2025 Q2	$1.13M	Sell	99,990 -51,754	-34%	-$561K	0.06%	321
2025 Q1	$1.53M	Buy	+151,744	New	+$1.64M	0.1%	241
2024 Q3	–	Sell	-106,522	Closed	-$1.13M	–	520
2024 Q2	$1.13M	Buy	+106,522	New	+$1.17M	0.07%	324

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

CenterBook Partners's ROIV Position: Q2 2026 in Review

CenterBook Partners reduced its Roivant Sciences (ROIV) stake by 61% in Q2 2026, selling an estimated $2.47M and leaving 53,116 shares worth $1.88M. The position accounts for 0.09% of the portfolio, ranked #243.

CenterBook Partners first reported a position in ROIV in Q2 2024 and has held it in 7 quarters since. The position peaked at $13.3M in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

CenterBook Partners held 53,116 shares of Roivant Sciences worth $1.88M as of Q2 2026.
CenterBook Partners sold 83,722 Roivant Sciences shares in Q2 2026, an estimated $2.47M.
Roivant Sciences made up 0.09% of CenterBook Partners's portfolio in Q2 2026, its #243 holding.
CenterBook Partners first reported a position in Roivant Sciences in Q2 2024 and has held it in 7 quarters since.
CenterBook Partners's Roivant Sciences position peaked at $13.3M in Q4 2025.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.